Will SMCI's DCBBS represent at least 10% of total revenue by Q2 FY2027 (Dec 2026)?
Current Prediction
Why This Question Matters
DCBBS is management's primary strategy for margin improvement and competitive differentiation. At 4% of profit in H1 FY2026, the gap between aspiration and reality is large. If DCBBS reaches 10% of revenue by December 2026, it validates the moat-widening thesis and supports margin recovery expectations. If it stalls, the NARROW competitive position assessment strengthens.
Prediction Distribution
Individual Predictions(9 runs)
DCBBS at 4% of profit implies very small revenue share. 10% of ~$12B is $1.2B quarterly. Ambitious in 9 months from small base.
Management says double-digit profit contribution by end CY2026. Higher margins mean lower revenue share. 10% revenue requires much more volume.
Expanding product line with 10+ categories. Vera Rubin transition could accelerate adoption. But 10% revenue is high bar.
Real initiative but SMCI may not separately disclose DCBBS revenue at all.
Management guided double-digit profit contribution, not revenue. 5-7% revenue more realistic.
Sovereign and large DC adoption could accelerate scaling.
New product line, early stage. 10% ambitious.
Expanding but from small base.
Could scale if adoption strong. Uncertain.
Resolution Criteria
Resolves YES if SMCI management discloses DCBBS revenue exceeding 10% of total revenue in Q2 FY2027 earnings report or any preceding quarter. Resolves NO if no such disclosure by February 15, 2027.
Resolution Source
SMCI earnings reports, investor presentations
Source Trigger
DCBBS revenue and profit contribution scaling
Full multi-lens equity analysis